Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

NCT00421174 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

Pneumonia
Idiopathic Pneumonia Syndrome

Interventions

DRUG: Etanercept
DRUG: Placebo plus corticosteroid

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]
[object Object]
[object Object]